CTRI/2019/04/018734尚未招募不适用
"An observational study to assess the lakshana of Pandu vyadhi in beta thalassemia patients with special reference to Hb-electrophoresis".
PDEAS college of ayurved and research centre nigdi1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年4月26日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Descriptive study
研究概览
简要总结
Corelation of symptoms of Pandu vyadhi with thalassemia patients can help in early detection of disease and hence help in proper management of disease through ayurved perspective.if one can diagnose the disease on the basis of this corelation the treatment of the disease can be started soon and life of patients can be prolonged or save and hence the topic is selected.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- All
入选标准
- •K/c/o beta thalassemia patients will be preferred on the basis of Hb-electrophoresis for present study.
排除标准
- •k/c/o HIV,HBV infection,hepatic failure or such major illness will be excluded.pregnant women Patient having haemorrhagic disorder.
- •Surgical intervention like splenectomy.
结局指标
主要结局
Descriptive study
时间窗: Samanya lakshana of Pandu vyadhi will be observed in beta thalassemia patients in single time.
次要结局
- Descriptive study(Doshaj lakshana of Pandu vyadhi will be observed in beta thalassemia patients in single time.)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
finding siddha based body constitutions for anaemic patientsCTRI/2023/02/049508National Institute of Siddha96
已完成
不适用
To study the characteristics of anaemic patients reporting at out patient department of national institute of siddha.CTRI/2018/06/014422Ayothidoss pandithar hospital500
已完成
4 期
A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®AnemiaNCT00117117Amgen2,423
已完成
不适用
Sophisticated Assessment of Disease Burden in Patients With Fabry DiseaseFabry DiseaseNCT01210196Shire36
招募中
不适用
Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.Idiopathic Pulmonary FibrosisNCT06445686Biosency30